Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIRAPK
2024-513856-14-00Phase 4Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of niraparib in high-grade serous carcinoma (HGSC), High-grade serous carcinoma of the fallopian tube (HGSC) and primary peritoneal cancer (PPC), sponsored by Hospices Civils de Lyon. Started Jul 2024; status: completed.
02
Drugs
niraparib
03
Conditions
high-grade serous carcinoma (HGSC)High-grade serous carcinoma of the fallopian tube (HGSC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on 2024-513856-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513856-14-00.